ATORVASTATIN NOBEL cpr pell 10 mg 30 pce

7680690980016 CH-69098 C10AA05 07.12.0.

Reimbursement limitations:

SORTIS

Chez les adultes de 18 à 75 ans, le traitement par statines est remboursé en …

ATORVASTATIN NOBEL cpr pell 10 mg 30 pce
ATORVASTATIN NOBEL cpr pell 10 mg 30 pce
ATORVASTATIN NOBEL cpr pell 10 mg 30 pce
1 / 3
google

Details

Product number
6909801
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
atorvastatinum 10 mg ut atorvastatinum calcicum trihydricum, calcii carbonas, lactosum monohydricum 32.075 mg, cellulosum microcristallinum, carmellosum natricum conexum, polysorbatum 80, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, lecithinum, xanthani gummi, pro compresso obducto corresp. natrium max. 1.13 mg.

Articles (1)

Atorvastatin NOBEL 10 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/09/2025
Patient information leaflet
Français
02/09/2025
Patient information leaflet
Italien
02/09/2025
Professional SmPC
Allemand
02/09/2025
Professional SmPC
Français
02/09/2025
Professional SmPC
Italien
02/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
32.075 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 30.25
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2024

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
69098
Drug name
Atorvastatin NOBEL, Filmtabletten
Galenic form
FILM
ATC Code
C10AA05
Authorization status
Z
Dispensation category
B
First authorization
06/06/2024
Authorization expiration date
05/06/2029
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
ATORVASTATIN NOBEL cpr pell 10 mg 30 pce
Description (DE)
ATORVASTATIN NOBEL Filmtabl 10 mg 30 Stk
Market launch
06/06/2024
Narcotic (BTM)
No

Original drug

Sortis, Filmtabletten
CHF 37.75
View original

Other packaging sizes

ATORVASTATIN NOBEL cpr pell 10 mg 90 pce
90 TABL
View
ATORVASTATIN NOBEL cpr pell 10 mg bte 220 pce
220 TABL
View
ATORVASTATIN NOBEL cpr pell 20 mg 30 pce
30 TABL
View
ATORVASTATIN NOBEL cpr pell 20 mg 100 pce
100 TABL
View
ATORVASTATIN NOBEL cpr pell 20 mg bte 100 pce
100 TABL
View
ATORVASTATIN NOBEL cpr pell 40 mg 30 pce
30 TABL
View
ATORVASTATIN NOBEL cpr pell 40 mg 100 pce
100 TABL
View
ATORVASTATIN NOBEL cpr pell 40 mg bte 120 pce
120 TABL
View
ATORVASTATIN NOBEL cpr pell 80 mg 30 pce
30 TABL
View
ATORVASTATIN NOBEL cpr pell 80 mg 90 pce
90 TABL
View